Stay updated on Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page
- Check5 days agoChange DetectedA new bibliographic citation by Reike MJ et al. was added to Publications, detailing a 2024 Clin Genitourin Cancer article related to the PURE-01 study. The page revision was updated to v3.6.3.SummaryDifference0.1%

- Check12 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer build of the page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now indicates recruitment has closed and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment header formatting and the revision label to v3.6.0 (removing the previous v3.5.5).SummaryDifference0.5%

- Check33 days agoChange DetectedThe page's revision label updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a minor update to the Study Details page. This likely reflects small fixes or clarifications rather than changes to the trial information.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page revision tag advanced from v3.5.3 to v3.5.4, signaling a minor update to the study record display and related metadata.SummaryDifference0.1%

- Check76 days agoChange DetectedThis updates the ClinicalTrials.gov page’s displayed revision/version number from v3.5.2 to v3.5.3, without changing any of the study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page.